Stock listing

NYSE American:SDEV Stablecoin Development Corporation Stock

Home listing (NYSE American) of Stablecoin Development Corporation

Follow Stablecoin Development Corporation into a list and get an email when it puts out news.

Share price · AMEX:SDEV

$0.50 USD -0.10 (-16.6%)

Close on Nov 20, 2026

Past year -89.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.467 – $0.591 USDNov 20, 2026
Volume
3.33M sharesNov 20, 2026
Market cap
$36.56M USDAt the close on Nov 20, 2026 · price × 73.12M shares outstanding
52-week range
$0.467 – $99.75 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$51.84M USDMedian day 3.33M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Stablecoin Development Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE American:SDEV · Home$0.50 USD-0.099 (-16.6%)3,327,312$0.557$0.591$0.467$0.599Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · AMEX:SDEV · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.50-0.099-16.6%$0.557$0.591$0.4673,327,312
$0.599-0.097-14.0%$0.60$0.64$0.5573,573,595
$0.697-0.009-1.3%$0.70$0.732$0.681,155,101
$0.706-0.075-9.6%$0.71$0.758$0.6912,031,974
$0.78-0.004-0.6%$0.796$0.796$0.7321,908,247
$0.785-0.057-6.8%$0.79$0.808$0.762,473,039
$0.842-0.008-1.0%$0.873$0.897$0.8232,140,208
$0.85-0.04-4.5%$0.87$0.919$0.832,448,018
$0.89-0.09-9.2%$0.941$0.975$0.892,372,595
$0.98+0.083+9.3%$0.905$0.991$0.8872,555,274
$0.897-0.07-7.3%$0.916$0.93$0.8564,041,372
$0.967+0.017+1.8%$0.939$1.01$0.9313,965,460
$0.95+0.03+3.3%$0.931$0.987$0.933,030,160
$0.92-0.09-8.9%$1.00$1.02$0.9083,237,566
$1.01-0.07-6.5%$1.03$1.05$0.964,639,900
$1.080.000.0%$1.04$1.09$1.005,255,900
$1.08+0.03+2.9%$1.07$1.15$0.998,137,500
$1.05+0.12+12.9%$0.99$1.25$0.9725,672,200
$0.93-0.07-7.0%$0.92$0.99$0.905,657,500
$1.00-0.10-9.1%$1.08$1.15$1.007,350,200
$1.100.000.0%$1.17$1.23$0.9936,466,100
$1.10+0.27+32.5%$0.94$1.65$0.90127,833,800
$0.83-0.01-1.2%$0.80$0.94$0.786,857,700
$0.84-0.04-4.5%$0.91$1.07$0.8016,066,800
$0.88-0.14-13.7%$1.01$1.02$0.887,114,500
$1.02+0.03+3.0%$1.01$1.15$0.8817,142,700
$0.99-0.26-20.8%$1.15$1.19$0.998,480,500
$1.25-0.16-11.3%$1.30$1.38$1.187,533,900
$1.41-0.13-8.4%$1.53$1.56$1.3510,048,700
$1.54-0.45-22.6%$1.99$2.00$1.5415,792,400
$1.99-0.79-28.4%$2.47$2.48$1.9221,136,800
$2.78-0.47-14.5%$3.27$3.31$2.6625,304,700
$3.25-0.69-17.5%$3.48$4.43$3.0464,332,000
$3.94-3.54-47.3%$9.71$9.82$3.2587,541,500
$7.48+3.82+104.4%$5.06$7.65$4.98153,283,900
$3.66+1.07+41.3%$3.60$4.54$3.40107,776,700
$2.59-0.68-20.8%$2.70$3.13$2.3729,312,200
$3.27+1.70+108.3%$1.64$3.93$1.62192,551,900
$1.57+0.08+5.4%$1.74$1.79$1.4714,831,100
$1.49+0.20+15.5%$1.58$1.83$1.4013,799,000
$1.29+0.17+15.2%$1.22$1.30$1.184,863,200
$1.12-0.15-11.8%$1.20$1.28$1.101,194,100
$1.27+0.27+27.0%$1.00$1.28$0.942,260,200
$1.00-0.04-3.8%$1.07$1.07$0.961,464,200
$1.04+0.20+23.8%$0.85$1.13$0.853,169,600
$0.840.000.0%$0.82$0.90$0.81276,400
$0.84-0.018-2.1%$0.86$0.87$0.81186,600
$0.858-0.026-3.0%$0.875$0.897$0.781270,187
$0.885-0.005-0.6%$0.874$0.893$0.865112,294
$0.89+0.03+3.5%$0.87$0.92$0.87191,200
$0.86-0.02-2.3%$0.87$0.89$0.86178,300
$0.88+0.01+1.1%$0.87$0.89$0.85211,500
$0.87-0.02-2.2%$0.89$0.92$0.87205,800
$0.890.000.0%$0.88$0.91$0.87160,900
$0.89+0.03+3.5%$0.86$0.95$0.86434,700
$0.860.000.0%$0.85$0.88$0.83266,900
$0.86-0.09-9.5%$0.92$0.92$0.85701,500
$0.95+0.02+2.2%$0.94$1.00$0.91457,100
$0.93-0.05-5.1%$0.97$0.98$0.93692,300
$0.98+0.01+1.0%$0.98$1.04$0.971,162,300
$0.97-0.07-6.7%$0.96$1.00$0.93600,300
$1.04-0.08-7.1%$1.04$1.05$0.9691,060,309
$1.12-0.02-1.8%$1.24$1.26$1.024,854,031
$1.14+0.02+1.8%$1.25$1.29$1.1010,489,300
$1.12+0.12+12.0%$1.07$1.17$0.983,258,600

Splits

4 splits since 2015 · AMEX:SDEV · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
1-for-35Consolidation
1-for-35Consolidation
1-for-25Consolidation
Ticker
NYSE American:SDEV
Asset type
Stock
Sector
Financials
Industry
Crypto & digital assets
Exchange
NYSE American
Currency
USD

What changed lately

Latest news

All Stablecoin Development Corporation news

Stablecoin Development Corporation on 6ix

Sector
Financials
Industry
Crypto & digital assets
News releases
2 in the last 12 months · 9 in all · newest Oct 29, 2026 · oldest 2007
Decks
19 decks · latest July 2024

Where Stablecoin Development Corporation is listed

ListingExchangeCountryCurrency
NYSE American:SDEV · Home listing · This pageNYSE AmericanUnited StatesUSD
BOATS:SDEVBOATSUnited StatesUSD
gettex:B9P1gettexGermanyEUR
Munich:B9P1MunichGermanyEUR
Frankfurt:B9P1FrankfurtGermanyEUR

Valuation

Price/book 0.2× against a median of 0.7×: the lowest of 11 Crypto & digital assets companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$29.41M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.2×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.42

Crypto & digital assets: the 10 companies nearest in size, of 107 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Stablecoin Development Corporation · AMEX:SDEVUS$36.56MUS$29.41Mn/an/an/a0.2×n/a0.0×1.42
Upexi, Inc. · NASDAQ:UPXIUS$40.76MUS$255.3Mn/a13.3×n/a0.8×n/a4.5×3.91
ZOOZ Strategy Ltd. · TASE:ZOOZUS$38.13MUS$15.59Mn/a63.1×n/a0.5×n/a0.0×n/a
SOL Strategies Inc. · CSE:HODLUS$36.28MUS$36.13Mn/a3.6×n/a0.7×−240.6%0.0×2.32
Metalpha Technology Holding Limited · NASDAQ:MATHUS$36.18M−US$428.4M28.2×−11.5×n/a0.7×3.5%0.0×0.88
KR1 PLC · LSE:KR1US$34.85MUS$28.90Mn/a4.5×n/a0.8×−735.3%0.0×n/a
BTCS Inc. · NASDAQ:BTCSUS$34.58M−US$122.9Mn/a−7.8×−2.4×0.4×−856.4%0.2×3.38
Hyperion DeFi, Inc. · NASDAQ:HYPDUS$32.22MUS$554.9M0.8×291×n/a0.2×n/a3.7×3.07
Avalanche Treasury Corporation · NASDAQ:AVATUS$30.56MUS$26.66Mn/a12.3×n/a0.2×−785.1%0.0×0.88
BITPLANET Co.,Ltd. · KRX:049470US$30.51MUS$21.63Mn/a1.1×n/a0.8×−68.2%0.1×n/a
SQD.AI Strategies AG · XETR:IPOKUS$29.74MUS$29.78Mn/a13.7×26.6×12.5×−110.0%0.0×n/a
Median of the othersUS$34.71MUS$27.78M14.5×8.4×12.1×0.7×−240.6%0.0×2.70

Team and board

Officers

OfficerRole
Michael KazleyChief Executive Officer
Tommy LawChief Financial Officer
Henry BlynnChief Operating Officer

Board

DirectorRole
Michael KazleyChief Executive Officer

Events

QuarterResultsShare move
Q3 2026Oct 29, 2026−6.5%
Q2 2026Jul 30, 2026+1.8%
Q1 2026May 22, 2026−11.5%
Q3 2025Nov 7, 2025+0.9%
Q2 2025Aug 29, 2025+38.2%
Q1 2025May 15, 2025−1.7%
Q3 2024Nov 7, 2024 · After close−1.4%
Q2 2024Aug 13, 2024 · After close−4.2%
Q1 2024May 10, 2024−11.1%
Q4 2023Mar 26, 2024 · After close−21.4%
All 20 quarters
QuarterResultsShare move
Q3 2023Nov 9, 2023 · After close−8.6%
Q2 2023Aug 10, 2023 · After close−6.8%
Q1 2023May 11, 2023 · After close−3.0%
Q3 2022Nov 14, 2022 · After close0.0%
Q2 2022Aug 11, 2022 · After close−9.7%
Q1 2022May 12, 2022 · After close+5.6%
Q4 2021Mar 30, 2022−6.3%
Quarter to Sep 30, 2021Nov 11, 2021 · After close−5.5%
Quarter to Jun 30, 2021Aug 12, 2021 · After close−3.1%
Quarter to Mar 31, 2021May 6, 2021 · After close−2.7%

Open Events

Decks

DeckKindSlidesDate
NovaBay Pharmaceuticals — Investor Presentation (July 2024)Investor deck18 slidesJuly 2024
NovaBay Pharmaceuticals — Corporate Update (April 2024)Corporate update22 slidesApr 22, 2024
NovaBay Pharmaceuticals — Life Science Investor Forum 2022Conference24 slidesSep 13, 2022
NovaBay Pharmaceuticals — Merger or Acquisition (January 2022)Merger or acquisition20 slidesJanuary 2022
NovaBay Pharmaceuticals — Merger or Acquisition (September 2021)Merger or acquisition11 slidesSep 29, 2021
NovaBay Pharmaceuticals — H.C. Wainwright Global Investment Conference 2021Conference20 slidesSeptember 2021
NovaBay Pharmaceuticals — Investor Presentation (June 2021)Investor deck19 slidesJune 2021
NovaBay Pharmaceuticals — Investor Presentation (April 2021)Investor deck19 slidesApril 2021
NovaBay Pharmaceuticals — Investor Presentation (March 2021)Investor deck19 slidesMarch 2021
NovaBay Pharmaceuticals — Investor Presentation (January 2020)Investor deck13 slidesJanuary 2020
All 19 decks
DeckKindSlidesDate
NovaBay Pharmaceuticals — Investor Presentation (July 2017)Investor deck29 slidesJul 17, 2017
NovaBay Pharmaceuticals — Investor Presentation (June 2017)Investor deck29 slidesJune 2017
NovaBay Pharmaceuticals — Investor Presentation (December 2016)Investor deck39 slidesDecember 2016
NovaBay Pharmaceuticals — Investor Presentation (September 2016)Investor deck26 slidesSeptember 2016
NovaBay Pharmaceuticals — Rodman & Renshaw Global Investor Conference 2015Conference29 slidesSep 14, 2015
NovaBay Pharmaceuticals — Investor Day (May 2015)Investor day105 slidesMay 19, 2015
NovaBay Pharmaceuticals — Investor Day (September 2013)Investor day30 slidesSep 17, 2013
NovaBay Pharmaceuticals — UCBE Analyst & Investor Event 2013Conference28 slidesSep 17, 2013
NovaBay Pharmaceuticals — BIO CEO Conference 2013Conference44 slidesFeb 11, 2013

Open Decks

Financings

RaiseDate
At-the-market programme of common stock
Tranche closed: US$45.9M raised
Oct 29, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue9.78M10.5M14.4M10.2M9.93M6.60M12.5M18.2M11.9M
Cost of revenue3.30M4.37M6.62M3.69M3.97M1.74M1.50M2.78M2.46M
Gross profit6.48M6.08M7.78M6.51M5.96M4.86M11.0M15.4M9.43M
Research and development42.0K34.0K174.0K44.0K285.0K184.0K259.0K410.0K1.37M
Operating income-8.44M-7.38M-4.10M-14.4M-8.86M-6.43M-9.40M-7.87M-7.31M-11.0M
Depreciation and amortization40.0K51.0K120.0K59.0K51.0K65.0K266.0K95.0K114.0K
EBITDA-7.34M-4.05M-14.3M-8.80M-6.38M-9.34M-7.61M-7.22M-10.9M
Income before tax-641.9M-8.75M-9.64M-10.6M-5.82M-11.0M-9.65M-6.54M-7.40M-13.1M
Income tax000005.00K6.00K4.00K3.00K2.00K
Net income-630.8M-7.22M-9.64M-10.6M-5.82M-11.0M-9.66M-6.54M-7.40M-13.2M
Earnings per share, basic-108.39-12.68-139.14-10.10-5.26-0.31-0.48-0.39-0.48-1.40
Earnings per share, diluted-150.00-0.31-0.48-0.46-0.48-1.40

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents7.96M430.0K2.92M5.36M7.50M12.0M6.94M3.18M3.20M9.51M
Short-term investments0
Receivables680.0K1.97M
Inventory0501.0K3.44M3.22M608.0K492.0K280.0K504.0K873.0K
Current assets8.68M1.94M7.15M11.3M13.2M14.2M9.38M8.61M8.99M14.5M
Property, plant and equipment44.0K87.0K119.0K193.0K84.0K110.0K201.0K471.0K371.0K
Goodwill0348.0K4.53M0
Total assets9.04M3.42M9.03M16.4M24.0M15.2M11.2M9.36M10.1M15.4M
Accounts payable257.0K109.0K906.0K1.08M1.04M302.0K331.0K551.0K466.0K455.0K
Current liabilities1.14M2.84M4.28M4.26M3.44M2.83M5.69M3.85M4.98M4.32M
Total liabilities640.5M3.55M5.72M5.84M13.8M2.92M10.2M4.41M7.49M8.28M
Shareholders' equity-631.8M-129.0K3.31M10.6M10.2M12.3M973.0K4.95M2.59M7.10M
Shares outstanding25.2M977.0K321.0K2.04M1.36M41.8M27.9M17.1M15.4M15.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-8.43M-7.50M-4.13M-6.65M-9.19M-4.72M-7.93M-5.57M-6.27M-11.7M
Capital spending-6.00K-19.0K-112.0K-52.0K-26.0K-19.0K-44.0K-244.0K-160.0K
Free cash flow-7.50M-4.15M-6.77M-9.24M-4.75M-7.95M-5.61M-6.51M-11.8M
Cash from investing1.06M-19.0K-112.0K-12.0M-26.0K-19.0K-44.0K-244.0K-160.0K
Cash from financing4.62M1.50M1.91M4.63M16.8M9.76M11.7M5.60M201.0K19.4M
Dividends paid-4.82M00
Change in cash7.32M-2.70M-2.24M-2.13M-4.45M5.01M3.75M-15.0K-6.31M7.60M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13D/A · Big-stake notice, amendedNov 19, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 19, 2026Big-stake noticeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
8-K · Current reportNov 17, 2026Current reportSEC
424B5 · ProspectusNov 17, 2026Offer documentSEC
S-3/A · Registration statement, amendedNov 16, 2026Offer documentSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
3 · Initial statement of ownershipNov 12, 2026Insider tradeSEC
8-K · Current reportNov 12, 2026Meeting outcomeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
8-K · Current reportOct 29, 2026ResultsSEC
10-Q · Quarterly reportOct 29, 2026Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 29, 2026Big-stake noticeSEC
S-3/A · Registration statement, amendedOct 26, 2026Offer documentSEC
S-3/A · Registration statement, amendedOct 6, 2026Offer documentSEC
8-K · Current reportOct 5, 2026ResultsSEC
8-K · Current reportSep 29, 2026Current reportSEC
DEF 14A · Proxy statementSep 28, 2026Meeting noticeSEC
S-3/A · Registration statement, amendedSep 16, 2026Offer documentSEC
3 · Initial statement of ownershipSep 8, 2026Insider tradeSEC
8-K · Current reportSep 8, 2026Management or board changeSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 21, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 17, 2026Big-stake noticeSEC
S-3 · Registration statementAug 11, 2026Offer documentSEC
8-K · Current reportJul 31, 2026ResultsSEC
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 24, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 24, 2026Big-stake noticeSEC
3 · Initial statement of ownershipJul 24, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 22, 2026Big-stake noticeSEC
8-K · Current reportJul 17, 2026Management or board changeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 17, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 17, 2026Big-stake noticeSEC
8-K · Current reportJun 17, 2026Material contractSEC
SCHEDULE 13D · Big-stake noticeMay 27, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 22, 2026Big-stake noticeSEC
8-K · Current reportMay 20, 2026ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 19, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 19, 2026Big-stake noticeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
4/A · Change in ownership, amendedApr 30, 2026Insider tradeSEC
4/A · Change in ownership, amendedApr 30, 2026Insider tradeSEC
4/A · Change in ownership, amendedApr 30, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 30, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 30, 2026Big-stake noticeSEC
10-K/A · Annual report, amendedApr 29, 2026Annual reportSEC
8-K · Current reportApr 29, 2026Current reportSEC
4 · Change in ownershipApr 21, 2026Insider tradeSEC
4 · Change in ownershipApr 9, 2026Insider tradeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
8-K · Current reportApr 6, 2026ResultsSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 2, 2026Big-stake noticeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
8-K · Current reportApr 1, 2026Management or board changeSEC
8-K · Current reportMar 23, 2026ResultsSEC
10-K · Annual reportMar 19, 2026Annual reportSEC
8-K · Current reportMar 12, 2026Meeting outcomeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 11, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialMar 2, 2026Meeting noticeSEC
8-K · Current reportFeb 20, 2026Current reportSEC
8-K · Current reportFeb 11, 2026Current reportSEC
DEF 14A · Proxy statementFeb 9, 2026Meeting noticeSEC
8-K · Current reportJan 30, 2026Current reportSEC
PRE 14A · Preliminary proxy statementJan 30, 2026Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 29, 2026Big-stake noticeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
8-K · Current reportJan 28, 2026Current reportSEC
DJan 27, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 21, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 21, 2026Big-stake noticeSEC
8-K · Current reportJan 20, 2026Material contractSEC
424B5 · ProspectusJan 20, 2026Offer documentSEC
8-K · Current reportJan 16, 2026Material contractSEC
EFFECT · Notice that a registration is effectiveNov 28, 2025Other filingsSEC
S-8 · Registration statement for employee plansNov 25, 2025Offer documentSEC
CORRESP · Letter to the SECNov 25, 2025Other filingsSEC
S-3/A · Registration statement, amendedNov 25, 2025Offer documentSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4/A · Change in ownership, amendedOct 22, 2025Insider tradeSEC
3/A · Initial statement of ownership, amendedOct 22, 2025Insider tradeSEC
8-K · Current reportOct 22, 2025Current reportSEC
8-K · Current reportOct 21, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 20, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 20, 2025Big-stake noticeSEC
4 · Change in ownershipOct 20, 2025Insider tradeSEC
4 · Change in ownershipOct 20, 2025Insider tradeSEC
4 · Change in ownershipOct 20, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 20, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 20, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 20, 2025Insider tradeSEC
8-K · Current reportOct 20, 2025Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
4 · Change in ownershipOct 17, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeOct 15, 2025Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeOct 15, 2025Big-stake noticeSEC
DEFA14A · Additional proxy materialOct 9, 2025Meeting noticeSEC
8-K · Current reportOct 9, 2025Management or board changeSEC
S-3 · Registration statementOct 3, 2025Offer documentSEC
DEF 14A · Proxy statementSep 23, 2025Meeting noticeSEC
ARS · Annual report to shareholdersSep 23, 2025Annual reportSEC
8-K · Current reportSep 18, 2025Current reportSEC
DEFA14A · Additional proxy materialSep 18, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementSep 10, 2025Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 4, 2025Big-stake noticeSEC
3 · Initial statement of ownershipAug 26, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeAug 26, 2025Big-stake noticeSEC
8-K · Current reportAug 26, 2025Current reportSEC
8-K · Current reportAug 19, 2025Material contractSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
SCHEDULE 13D · Big-stake noticeJun 4, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
8-K · Current reportApr 22, 2025Meeting outcomeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
3 · Initial statement of ownershipApr 7, 2025Insider tradeSEC
10-K · Annual reportApr 2, 2025Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2025Explanation requestSEC
DEF 14A · Proxy statementMar 19, 2025Meeting noticeSEC
8-K · Current reportMar 11, 2025Material contractSEC
DEFA14A · Additional proxy materialMar 7, 2025Meeting noticeSEC
8-K · Current reportMar 7, 2025Material contractSEC
PRE 14A · Preliminary proxy statementFeb 18, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2025Big-stake noticeSEC
DEFA14A · Additional proxy materialFeb 4, 2025Meeting noticeSEC
8-K · Current reportFeb 4, 2025Meeting outcomeSEC
8-K · Current reportJan 23, 2025Acquisition or disposalSEC
DEFA14A · Additional proxy materialJan 23, 2025Meeting noticeSEC
8-K · Current reportJan 22, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeJan 10, 2025Big-stake noticeSEC
8-K · Current reportJan 10, 2025Acquisition or disposalSEC
8-K · Current reportDec 19, 2024Meeting outcomeSEC
DEFA14A · Additional proxy materialDec 11, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialDec 9, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialNov 26, 2024Meeting noticeSEC
8-K · Current reportNov 22, 2024Meeting outcomeSEC
DEFA14A · Additional proxy materialNov 15, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialNov 13, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialNov 12, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialNov 12, 2024Meeting noticeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
DEFA14A · Additional proxy materialNov 6, 2024Meeting noticeSEC
8-K · Current reportNov 6, 2024Material contractSEC
DEFA14A · Additional proxy materialOct 29, 2024Meeting noticeSEC
8-K · Current reportOct 29, 2024Current reportSEC
8-K · Current reportOct 16, 2024ResultsSEC
DEFM14AOct 16, 2024Meeting noticeSEC
PREM14ASep 25, 2024Other filingsSEC
DEFA14A · Additional proxy materialSep 20, 2024Meeting noticeSEC
8-K · Current reportSep 20, 2024Material contractSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportJul 29, 2024Material contractSEC
424B4 · ProspectusJul 26, 2024Offer documentSEC
POS EXJul 26, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveJul 26, 2024Other filingsSEC
S-1/A · Registration statement, amendedJul 24, 2024Offer documentSEC
CORRESP · Letter to the SECJul 22, 2024Other filingsSEC
CORRESP · Letter to the SECJul 22, 2024Other filingsSEC
S-1/A · Registration statement, amendedJul 12, 2024Offer documentSEC
FWP · Free writing prospectusJul 11, 2024Offer documentSEC
8-K · Current reportJul 11, 2024ResultsSEC
FWP · Free writing prospectusJul 10, 2024Offer documentSEC
S-1/A · Registration statement, amendedJul 10, 2024Offer documentSEC
424B3 · ProspectusJun 28, 2024Offer documentSEC
DJun 28, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveJun 28, 2024Other filingsSEC
CORRESP · Letter to the SECJun 25, 2024Other filingsSEC
UPLOAD · Letter from the SECJun 25, 2024Other filingsSEC
UPLOAD · Letter from the SECJun 25, 2024Other filingsSEC
S-1 · Registration statementJun 21, 2024Offer documentSEC
S-8 · Registration statement for employee plansJun 21, 2024Offer documentSEC
S-1 · Registration statementJun 20, 2024Offer documentSEC
8-K · Current reportJun 14, 2024Material contractSEC
8-K · Current reportJun 7, 2024Current reportSEC
8-K · Current reportMay 31, 2024Current reportSEC
8-K/A · Current report, amendedMay 31, 2024Current reportSEC
4 · Change in ownershipMay 30, 2024Insider tradeSEC
4 · Change in ownershipMay 30, 2024Insider tradeSEC
4 · Change in ownershipMay 30, 2024Insider tradeSEC
4 · Change in ownershipMay 30, 2024Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Stablecoin Development Corporation’s releases · as of Oct 29, 2026

Common shares
73,117,016
Fully diluted
73,117,016

Fully diluted

LineSharesAs of
Common shares73,117,016Oct 26, 2026

Share count over time

CountShares
Oct 26, 202673,117,016

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard925K1.3%US$2.39MSep 30, 2026
Geode Capital506K0.69%US$1.31MSep 30, 2026
BlackRock388K0.53%US$1.01MSep 30, 2026
State Street117K0.16%US$303KSep 30, 2026
Hrt Financial LP111K0.15%US$287KSep 30, 2026
Anson Funds Management LP108K0.15%US$280KSep 30, 2026
Northern Trust93,6420.13%US$243KSep 30, 2026
UBS45,4030.06%US$118KSep 30, 2026
Millennium42,2020.06%US$109KSep 30, 2026
BNY28,0330.04%US$72,606Sep 30, 2026
All 21 holders
HolderSharesOf the companyValueAs of
Goldman Sachs21,9260.03%US$56,788Sep 30, 2026
Citigroup Inc3,791<0.01%US$9,819Sep 30, 2026
IFP Advisors, Inc3,000<0.01%US$7,770Sep 30, 2026
SBI Securities Co., Ltd.1,120<0.01%US$2,901Sep 30, 2026
RBC199<0.01%US$1,000Sep 30, 2026
Barclays20<0.01%US$52Sep 30, 2026
Morgan Stanley6<0.01%US$16Sep 30, 2026
Farther Finance Advisors, LLC1<0.01%US$3Sep 30, 2026
Mosley Wealth Management1<0.01%US$1Sep 30, 2026
Nvwm, LLC1<0.01%US$3Sep 30, 2026
Fidelity00.00%Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund282K0.39%US$296KJun 30, 2026
Fidelity Extended Market Index Fund139K0.19%US$176KMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF57,8750.08%US$60,769Jun 30, 2026
Fidelity Total Market Index Fund47,8610.07%US$60,783May 31, 2026
Vanguard Total Stock Market Index Fund44,3070.06%US$46,522Jun 30, 2026
Fidelity Series Total Market Index Fund39,5140.05%US$50,183May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
R01 Capital Manager LLC
10% owner
Sale24,720USD 1.09US$26,945Jun 15, 2026
Framework Ventures Management LLC
10% owner
Sale24,720USD 1.09US$26,945Jun 15, 2026
Kazley Michael John
Director, Officer: Chief Executive Officer, 10% owner
Sale24,720USD 1.09US$26,945Jun 15, 2026

Big stakes

StakeStakeSharesDateFiling
R01 Fund LP30.70%22.7MNov 17, 2026Schedule 13D
Framework Ventures IV L.P.30.70%22.7MNov 17, 2026Schedule 13D
Tether Global Investments Fund, S.I.C.A.F., S.A.9.99%5.62MJun 30, 2026Schedule 13G
Sky Frontier Foundation9.90%8.12MOct 21, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Lazar
Other companies: Aterian, Inc. (Chair of the Board · Since at least Apr 27, 2026); Quantum Cyber N.V. (CEO · Since at least Feb 13, 2026); Sow Good Inc. (Chief Executive Officer and Chair of the Board · Since at least Dec 31, 2025); Indaptus Therapeutics, Inc. (Director · Since at least Dec 22, 2025); Kala Bio, Inc. (Chief Executive Officer, Director · Since at least Nov 23, 2025); Bio Green Med Solution, Inc. (Interim CEO · Jan 2, 2025 – Feb 26, 2025 · Past); LQR House Inc. (President, Director · Oct 15, 2024 – Apr 2, 2025 · Past); CapForce Inc. (Chief Executive Officer, Director · Mar 25, 2024 – Jul 30, 2024 · Past); FiEE, Inc (Director · Dec 29, 2023 – Feb 18, 2025 · Past); Titan Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 24, 2023 – Jul 26, 2023 · Past)
Chief Executive Officer, Director · Since at least Aug 19, 2025
Gail J Maderis
Other companies: Durect Corporation (Director · Since at least Jan 4, 2021); Allarity Therapeutics, Inc. (Director · Dec 20, 2021 – Dec 20, 2021 · Past); Acer Therapeutics Inc (Director · Oct 27, 2011 – Sep 30, 2016 · Past)
Director · Oct 5, 2010 – May 30, 2019 · Past
Harry F Hixson Jr
Other companies: Arena Pharmaceuticals Inc (Director · Jul 28, 2006 – Jun 13, 2016 · Past); Sequenom Inc (Director · Jun 6, 2006 – Feb 10, 2015 · Past)
Director · Jan 14, 2009 – Jan 4, 2010 · Past
Todd Erik Zavodnick
Other companies: Revance Therapeutics, Inc. (CCO & President, · Sep 18, 2017 – Oct 15, 2018 · Past); Zeltiq Aesthetics Inc (President, International · Feb 1, 2016 – Apr 28, 2017 · Past)
Director · May 9, 2016 – May 30, 2019 · Past
Andrew D Jones
Other companies: Hyperion DeFi, Inc. (Chief Financial Officer · Aug 30, 2024 – Aug 30, 2024 · Past)
CFO · May 4, 2020 – Feb 15, 2023 · Past
Charles Cashion
Other companies: Histogen Inc (SVP, Finance, CFO and Sec. · Jul 24, 2013 – Jan 26, 2017 · Past)
Director · Oct 24, 2007 – Jan 2, 2015 · Past
Julie Garlikov
Other companies: Newage Inc (Chief Marketing Officer · Nov 4, 2019 – Dec 10, 2019 · Past)
Director · Since at least Jan 27, 2022
Keith R Bley
Other companies: NeurogesX Inc (SVP, Nonclinical R & D · Apr 28, 2007 – Feb 3, 2011 · Past)
SVP Product Development · Mar 4, 2013 – Sep 26, 2014 · Past
Mark M Sieczkarek
Other companies: Big Digital Energy, Inc. (Director · Apr 23, 2019 – Aug 11, 2020 · Past)
Director · May 30, 2019 – May 30, 2019 · Past
Paul E Freiman
Other companies: Neurotrope Inc (See Remarks, Director · Aug 29, 2014 – Nov 19, 2015 · Past)
Director · Since at least Oct 24, 2007
All 37 people
PersonSeat
Roy J Wu
Other companies: Genelabs Technologies Inc (VP, BUSINESS DEVELOPMENT · Dec 30, 2005 – Jan 7, 2009 · Past)
SVP Bus & Corp Development · Jul 28, 2009 – Oct 5, 2015 · Past
Swan Sit
Other companies: Edgewell Personal Care Company (Director · Since at least Sep 2, 2020)
Director · Since at least Dec 17, 2019
Audrey KuninChief Product Officer · Nov 5, 2021 – Dec 6, 2022 · Past
Behzad KhosroviSVP Product Development · Mar 14, 2007 – Jan 10, 2013 · Past
Colin ScottVP, Clinical Research and Dev · Oct 24, 2007 – Feb 1, 2011 · Past
David Garcia RiosDirector · Since at least Sep 2, 2026
Henry BlynnChief Operating Officer · Since at least Jul 15, 2026
Jason Philip RaleighInterim CFO and Treasurer · Mar 8, 2019 – Jun 10, 2019 · Past
Jeffrey KuninPresident, DERMAdoctor, LLC · Nov 5, 2021 – Dec 6, 2022 · Past
John James O'ReillySVP Business and Corporate Dev, Director · Oct 24, 2007 – Feb 1, 2011 · Past
John Joseph McGovernInt Pres, CEO, CFO & Treasurer · Jul 17, 2017 – Oct 9, 2018 · Past
Justin HallCEO, GC and Director, Director · Dec 29, 2015 – Sep 14, 2022 · Past
Mark Brian AndersonCSO · Oct 15, 2009 – Oct 27, 2011 · Past
Michael KazleyChief Executive Officer, Director · Since at least Oct 9, 2025
Mijia WuDirector · Jan 26, 2016 – May 28, 2024 · Past
Ramin NajafiChief Executive Officer, Director · Sep 29, 2011 – Aug 19, 2015 · Past
Russell A HoonSenior Vice President · Dec 15, 2014 – Apr 14, 2015 · Past
Thomas J PaulsonCFO · Jan 9, 2008 – Jan 25, 2017 · Past
Tommy LawChief Financial Officer · Since at least Feb 16, 2023
Tommy LawChief Financial Officer · Since at least Mar 23, 2026
Wang XuNEO - Sr Mgr and Controller · Dec 31, 2019 – Aug 20, 2020 · Past
Xiaopei WangDirector · Jul 20, 2019 – May 26, 2020 · Past
Xiaoyan LiuDirector · Jan 26, 2016 – Jan 3, 2017 · Past
Xinzhou LiDirector · Jul 3, 2017 – May 21, 2021 · Past
Yanbin LiuDirector · Mar 21, 2018 – May 31, 2018 · Past
Yenyou ZhengDirector · Since at least Sep 11, 2019
Yongxiang ZhengDirector · Since at least Jan 27, 2022

Open People

Log in to ask 6ix AI your own questions about Stablecoin Development Corporation.